Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

During the Trading Day
199.29 +0.53 / +0.27%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
199.29 0.00 / 0.00%
Volume: 24.1K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 2
Quarter 3
Quarter 4
Quarter 1
Operating ActivitiesNet Income / Starting Line166.5M177.7M153.3M91.3M
Total Other Cash Flow-94.1M20.8M104.4M8.5M
Funds From Operations28.1M159.8M282.8M85.5M
Funds From/For Other Operating Expenses-78.1M-121.7M-631.0K62.5M
Net Cash Flow - Operating Activities106.2M281.5M283.5M23.0M
InvestingIncrease In Investments-158.1M-174.4M-188.4M-168.6M
Decrease In Investments176.7M122.1M221.4M176.3M
Capital Expenditures-43.5M-22.7M-52.8M-57.1M
Other Investing - Uses0.00-628.0K121.0K0.00
Other Investing - Sources-44.0K-26.0K--951.0K
Net Cash Flow Investing81.0K-75.6M-57.2M-48.4M
FinancingShort Term Borrowings0.
Long Term Borrowings0.
Long Term Debt Reduction-12.0M-12.0M-12.0M-12.0M
Net Proceeds Stock Sale276.3M-229.0M36.7M24.9M
Common Preferred Redeemed-156.5M-104.6M-19.5M-60.0M
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing-130.4M286.3M-35.2M52.5M
Other Uses - Financing39.0K38.0K142.0K303.0K
Net Cash Flow - Financing-22.6M-59.4M-30.1M5.1M
Exchange RateEffect of Exchange Rate on Cash109.0K-6.4M-4.3M-6.9M
Net Change In Cash83.7M146.6M196.2M-20.3M